Concepedia
Statistics
Publications
27
Citations
1.6K
H-Index
21
Active since
2001
Affiliations
Eli Lilly (United Kingdom)(Current)
Universität Ulm
Eli Lilly (United States)
Saarland University
University College London
Daniel Ursu is an author at Eli Lilly (United Kingdom) specializing in life sciences, pharmacology, and neuroscience.
Publications per year
2001–2019
Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice
Martin M. Jendryka, Monika Palchaudhuri, Daniel Ursu et al. · Scientific Reports · 2019 · 323 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +15
A mutation in the GABA<sub>A</sub> receptor α<sub>1</sub>‐subunit is associated with absence epilepsy
Snezana Maljevic, Klaus Krampfl, Joana Cobilanschi et al. · Annals of Neurology · 2006 · 206 citations
Life Sciences, Genetics, Neuroscience +17
Passive muscle stiffness may be influenced by active contractility of intramuscular connective tissue
Robert Schleip, I.L. Naylor, Daniel Ursu et al. · Medical Hypotheses · 2005 · 170 citations
Natural Sciences, Anatomy, Physiology +15
Epilepsy-associated GRIN2A mutations reduce NMDA receptor trafficking and agonist potency – molecular profiling and functional rescue
Laura Addis, Jasmeet Virdee, Lewis R. Vidler et al. · Scientific Reports · 2017 · 94 citations · Full text
Life Sciences, Neuroscience, Pharmacology +17
Gain and Loss of Function of P2X<sub>7</sub> Receptors: Mechanisms, Pharmacology and Relevance to Diabetic Neuropathic Pain
Daniel Ursu, Philip J. Ebert, Emily Langron et al. · Molecular Pain · 2014 · 78 citations · Full text
Medicine, Molecular Genetics, Pharmacology +17
1–5 of 27